The global sinus dilation devices market is anticipated to grow at a considerable CAGR of 9% during the forecast period (2022-2028). The market is excepted to grow due to various new technologies developed, adopted, and launched in the market such as balloon sinus dilation system, SINUVA sinus implant, endoscopic sinus surgery, and others propelling the sinus dilation devices market growth. Furthermore, key companies operating in the industry are highly inclined towards the adoption of various new technology-based products. Moreover, companies are also adopting different growth strategies including capacity expansion, partnerships, mergers and acquisitions, geographical expansion, new product launches, and product innovation to remain competitive in the marketplace.
Browse the full report description of “Global Sinus Dilation Devices Market Size, Share & Trends Analysis Report by Type (Sinus Stents, Balloon Sinus Dilation, Endoscopic Sinus Surgery, and Hand Handheld Instrument), and by End-User (Hospitals and Clinics, and Ambulatory Surgical Centers) Forecast Period (2022-2028)” at https://www.omrglobal.com/industry-reports/sinus-dilation-devices-market
For instance,
• In September 2021, Acclarent, Inc., has launched the first-ever AI-powered ENT technology in the US. The new software contains TruSeg and TruPath and is used with TruDi Navigation System and it leverages machine learning algorithm. This is designed to help surgeons avoid unintended consequences of access to safe, minimally invasive, long-term solutions for patients in need of sinus surgery.
• In July 2021, Intersect ENT has launched its VenSure balloon sinus dilation system and Cube 4D navigation systems. This system is used in procedures that improve debilitating chronic rhinosinusitis (CRS) symptoms and Cube 4D navigation system allows 3D facial registration, pinpoint accuracy, and improved workflow efficiency for balloon sinus dilation.
• In February 2021, Intersect ENT launched a Straight Delivery System packaged with the company's PROPEL Mini (mometasone furoate) Sinus Implant and is now available in the US. This new combination also has received approval from US Food and Drug Administration FDA and it is for ethmoid sinus for maximum tissue apposition.
Market Coverage
• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
o By Product
o By Services
o By Application
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- Johnson & Johnson Services, Inc., Medtronic Plc., Olympus Corp, Smith & Nephew Healthcare, Stryker Corp., Teleflex Inc., and others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Sinus Dilation Devices Market Report Segment
By Type
By End-User
Global Sinus Dilation Devices Market Report by Region
North America
• US
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/sinus-dilation-devices-market